Medicamen Biotech Limited — Others, 31-03-2025: Trading Window

The Trading Window for Medicamen Biotech Limited will be closed for all Directors, Designated Persons, and Connected Persons from April 1, 2025, until 48 hours post the announcement of the financial results for the quarter and year ending March 31, 2025. This measure is in line with internal compliance protocols to prevent insider trading. Investors should view this as a precautionary step that ensures transparency, though it may lead to short-term inactivity among insiders. Overall, this could foster a positive outlook among shareholders concerned about governance and trading integrity.